Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 (original) (raw)
- Letter
- Published: 16 July 2006
- Ian R. Mackenzie2 na1,
- Stuart M. Pickering-Brown5,6 na1,
- Jennifer Gass1,
- Rosa Rademakers1,
- Caroline Lindholm3,
- Julie Snowden6,
- Jennifer Adamson1,
- A. Dessa Sadovnick3,4,
- Sara Rollinson5,
- Ashley Cannon1,
- Emily Dwosh4,
- David Neary6,
- Stacey Melquist1,
- Anna Richardson6,
- Dennis Dickson1,
- Zdenek Berger1,
- Jason Eriksen1,
- Todd Robinson1,
- Cynthia Zehr1,
- Chad A. Dickey1,
- Richard Crook1,
- Eileen McGowan1,
- David Mann6,
- Bradley Boeve7,
- Howard Feldman3 &
- …
- Mike Hutton1
Nature volume 442, pages 916–919 (2006)Cite this article
- 10k Accesses
- 1602 Citations
- 45 Altmetric
- Metrics details
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years1. A large proportion of FTD patients (35–50%) have a family history of dementia, consistent with a strong genetic component to the disease2. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17)3. The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau3,4. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787–D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology5,6,7,8,9,10,11,12. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions11,12,13. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation14. PGRN has also been strongly linked to tumorigenesis14. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt–Jakob disease, motor neuron disease and Alzheimer's disease15,16. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Brun, A. et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J. Neurol. Neurosurg. Psychiatry 57, 416–418 (1994)
Article Google Scholar - Chow, T. W., Miller, B. L., Hayashi, V. N. & Geschwind, D. H. Inheritance of frontotemporal dementia. Arch. Neurol. 56, 817–822 (1999)
Article CAS Google Scholar - Hutton, M. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705 (1998)
Article ADS CAS Google Scholar - Ingram, E. M. & Spillantini, M. G. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8, 555–562 (2002)
Article CAS Google Scholar - Rademakers, R. et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol. Psychiatry 7, 1064–1074 (2002)
Article CAS Google Scholar - Rosso, S. M. et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21–22. Brain 124, 1948–1957 (2001)
Article CAS Google Scholar - Lendon, C. L. et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21–22. Neurology 50, 1546–1555 (1998)
Article CAS Google Scholar - Kertesz, A. et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54, 818–827 (2000)
Article CAS Google Scholar - Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997)
Article CAS Google Scholar - Bird, T. D. et al. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 48, 949–954 (1997)
Article CAS Google Scholar - van der Zee, J. et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 129, 841–852 (2006)
Article Google Scholar - Mackenzie, I. R. et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129, 853–867 (2006)
Article Google Scholar - Rademakers, R. et al. In IPSEN Meeting Research and Perspectives in Alzheimer's Disease: Genotype–Proteotype–Phenotype Relationships in Neurodegenerative Diseases (ed. Cummings, J.) 117–137 (Springer, Paris, 2005)
Google Scholar - He, Z. & Bateman, A. Progranulin (granulin–epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J. Mol. Med. 81, 600–612 (2003)
Article CAS Google Scholar - Malaspina, A., Kaushik, N. & de Belleroche, J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77, 132–145 (2001)
Article CAS Google Scholar - Baker, C. A. & Manuelidis, L. Unique inflammatory RNA profiles of microglia in Creutzfeldt–Jakob disease. Proc. Natl Acad. Sci. USA 100, 675–679 (2003)
Article ADS CAS Google Scholar - Neary, D., Snowden, J. S. & Mann, D. M. Classification and description of frontotemporal dementias. Ann. NY Acad. Sci. 920, 46–51 (2000)
Article ADS CAS Google Scholar - Trojanowski, J. Q. & Dickson, D. Update on the neuropathological diagnosis of frontotemporal dementias. J. Neuropathol. Exp. Neurol. 60, 1123–1126 (2001)
Article CAS Google Scholar - Mackenzie, I. R. & Feldman, H. H. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J. Neuropathol. Exp. Neurol. 64, 730–739 (2005)
Article Google Scholar - Foster, N. L. et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41, 706–715 (1997)
Article CAS Google Scholar - Mackenzie, I. R. & Feldman, H. Neuronal intranuclear inclusions distinguish familial FTD–MND type from sporadic cases. Acta Neuropathol. (Berl.) 105, 543–548 (2003)
Google Scholar - Cruts, M. et al. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region. Hum. Mol. Genet. 14, 1753–1762 (2005)
Article CAS Google Scholar - Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature advance online publication, doi:10.1038/nature05017 (16 July 2006)
- Maquat, L. E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Rev. Mol. Cell Biol. 5, 89–99 (2004)
Article CAS Google Scholar - Daniel, R., He, Z., Carmichael, K. P., Halper, J. & Bateman, A. Cellular localization of gene expression for progranulin. J. Histochem. Cytochem. 48, 999–1009 (2000)
Article CAS Google Scholar - Capsoni, S. et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl Acad. Sci. USA 97, 6826–6831 (2000)
Article ADS CAS Google Scholar - Salehi, A., Delcroix, J. D. & Swaab, D. F. Alzheimer's disease and NGF signaling. J. Neural Transm. 111, 323–345 (2004)
Article CAS Google Scholar - Lu, R. & Serrero, G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proc. Natl Acad. Sci. USA 98, 142–147 (2001)
Article ADS CAS Google Scholar - Tangkeangsirisin, W. & Serrero, G. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25, 1587–1592 (2004)
Article CAS Google Scholar - Greenway, M. J. et al. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nature Genet. 38, 411–413 (2006)
Article CAS Google Scholar - He, Z., Ong, C. H., Halper, J. & Bateman, A. Progranulin is a mediator of the wound response. Nature Med. 9, 225–229 (2003)
Article CAS Google Scholar
Acknowledgements
We thank the FTD research team at Vancouver Coastal Health and the University of British Columbia, and particularly G. Y. R. Hsiung, for identification and follow-up of FTD families; D. Warden, P. Whitbread and E. King (OPTIMA project, Oxford, UK) for assisting with collection of UBC17 family samples; J. Chow (Department of Pathology, University of British Columbia) for help in performing the PGRN immunohistochemistry; and M. Yue, J. Gonzales (Mayo Clinic), T. de Pooter and M. Van den Broeck (University of Antwerp) for technical support. This research was funded as part of the Mayo Clinic ADRC grant from the National Institute on Aging (to M.H.), the Mayo Foundation (M.H.), and the Robert and Clarice Smith Fellowship program (to S.M.). I.R.M. and H.F. were funded by the Canadian Institutes of Health research operating grant. S.M.P.-B. received grants from the Medical Research Council (UK) and the Motor Neuron Disease Association. R.R. is a postdoctoral fellow of the Fund for Scientific Research Flanders and a visiting scientist from the Neurodegenerative Brain Diseases Group of the Department of Molecular Genetics, VIB, University of Antwerp, Belgium. Finally, we acknowledge and thank the families who contributed samples, as without them this study would not have been possible.
Author information
Author notes
- Matt Baker, Ian R. Mackenzie and Stuart M. Pickering-Brown: *These authors contributed equally to this work
Authors and Affiliations
- Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Florida, 32224, Jacksonville, USA
Matt Baker, Jennifer Gass, Rosa Rademakers, Jennifer Adamson, Ashley Cannon, Stacey Melquist, Dennis Dickson, Zdenek Berger, Jason Eriksen, Todd Robinson, Cynthia Zehr, Chad A. Dickey, Richard Crook, Eileen McGowan & Mike Hutton - Department of Pathology,
Ian R. Mackenzie - Division of Neurology,
Caroline Lindholm, A. Dessa Sadovnick & Howard Feldman - Department of Medical Genetics, University of British Columbia, 2211 Wesbrook Mall, V6T 2B5, British Columbia, Vancouver, Canada
A. Dessa Sadovnick & Emily Dwosh - Division of Laboratory and Regenerative Medicine, Department of Medicine, University of Manchester, Oxford Road, M13 9PT, Manchester, UK
Stuart M. Pickering-Brown & Sara Rollinson - Centre for Clinical Neurosciences, University of Manchester, Greater Manchester Neurosciences Centre, Hope Hospital, M6 8HD, Salford, UK
Stuart M. Pickering-Brown, Julie Snowden, David Neary, Anna Richardson & David Mann - Department of Neurology, Mayo Clinic College of Medicine, Minnesota, 55905, Rochester, USA
Bradley Boeve
Authors
- Matt Baker
You can also search for this author inPubMed Google Scholar - Ian R. Mackenzie
You can also search for this author inPubMed Google Scholar - Stuart M. Pickering-Brown
You can also search for this author inPubMed Google Scholar - Jennifer Gass
You can also search for this author inPubMed Google Scholar - Rosa Rademakers
You can also search for this author inPubMed Google Scholar - Caroline Lindholm
You can also search for this author inPubMed Google Scholar - Julie Snowden
You can also search for this author inPubMed Google Scholar - Jennifer Adamson
You can also search for this author inPubMed Google Scholar - A. Dessa Sadovnick
You can also search for this author inPubMed Google Scholar - Sara Rollinson
You can also search for this author inPubMed Google Scholar - Ashley Cannon
You can also search for this author inPubMed Google Scholar - Emily Dwosh
You can also search for this author inPubMed Google Scholar - David Neary
You can also search for this author inPubMed Google Scholar - Stacey Melquist
You can also search for this author inPubMed Google Scholar - Anna Richardson
You can also search for this author inPubMed Google Scholar - Dennis Dickson
You can also search for this author inPubMed Google Scholar - Zdenek Berger
You can also search for this author inPubMed Google Scholar - Jason Eriksen
You can also search for this author inPubMed Google Scholar - Todd Robinson
You can also search for this author inPubMed Google Scholar - Cynthia Zehr
You can also search for this author inPubMed Google Scholar - Chad A. Dickey
You can also search for this author inPubMed Google Scholar - Richard Crook
You can also search for this author inPubMed Google Scholar - Eileen McGowan
You can also search for this author inPubMed Google Scholar - David Mann
You can also search for this author inPubMed Google Scholar - Bradley Boeve
You can also search for this author inPubMed Google Scholar - Howard Feldman
You can also search for this author inPubMed Google Scholar - Mike Hutton
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence toIan R. Mackenzie or Mike Hutton.
Ethics declarations
Competing interests
Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.
Supplementary information
Supplementary Notes
This file contains Supplementary Methods, Supplementary Table 1 and Supplementary Figures 1–4. (PDF 2631 kb)
Rights and permissions
About this article
Cite this article
Baker, M., Mackenzie, I., Pickering-Brown, S. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.Nature 442, 916–919 (2006). https://doi.org/10.1038/nature05016
- Received: 12 May 2006
- Accepted: 29 June 2006
- Published: 16 July 2006
- Issue Date: 24 August 2006
- DOI: https://doi.org/10.1038/nature05016
This article is cited by
Editorial Summary
Dementia-causing mutation
Two groups of neuroscientists have discovered that a mutation in the progranulin gene, which encodes a growth factor, can cause frontotemporal dementia (FTD). The condition, the second most common form of dementia among under-65s, impairs memory and personality and may also affect movement. The discovery may help to resolve confusion over the cause of the disease — mutations in a neighbouring gene called microtubule-associated protein tau were shown previously to be associated with some, but not all, cases of FTD.